Exclusive global license outside of Greater China for MRG007, a novel antibody drug conjugate (ADC) in development for gastrointestinal (GI) cancers First Investigational New Drug (IND) submission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback